Multiple Manufacturers

CAPECITABINE

Manufacturer:

Multiple Manufacturers

Capecitabine HCPCS:

J8521

HCPCS Code Descriptor:

Capecitabine, oral, 500 mg

Category:

J Code

Capecitabine NDCs:

00378-2512-78, 62135-0784-12, 16714-0468-01, 00004-1101-50, 70756-0816-22, 68001-0488-07, 72485-0205-12, 69097-0948-08, 16729-0073-29, 65162-0844-16, 00054-0272-23, 64980-0277-12, 00093-7474-89, 51079-0510-05

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00378-2512-78, 70756-0816-22, 69097-0948-08, 16729-0073-29, 64980-0277-12, 51079-0510-05

About Capecitabine:

CAPECITABINE is a medication manufactured by multiple manufacturers and aligned to the J Code: J8521. CAPECITABINE is administered via the oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J8521 Added Date:

January 1, 2000

J8521 Effective Date:

January 1, 2016

J8521 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Capecitabine billing and coding information.
Capecitabine patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
CAPECITABINE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for CAPECITABINE. Please check back in a few weeks.